Vericel

VCEL US Health Care Biotechnology
S&P 600
$38.34
+1.24%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Vericel belong to?
Vericel operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of VCEL?
As of the latest available quote, VCEL traded at $38.34. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of VCEL?
Vericel has a price-to-earnings (P/E) ratio of about 79.88. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of VCEL?
The market capitalisation of Vericel is approximately $1.98B.
Is Vericel profitable?
For its latest reported financial year, Vericel recorded a net profit margin of about 5.98%.
Does VCEL pay a dividend?
Vericel does not currently show a dividend yield in our data.
What is the return on equity (ROE) of VCEL?
Vericel has a return on equity (ROE) of about 4.46%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of VCEL?
Over the past 52 weeks, VCEL has traded between a low of $28.95 and a high of $49.32.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.